Almost half of New York women who had been trying to become pregnant before COVID-19 stopped trying during the first few months of the pandemic, according to survey results published in JAMA Network Open yesterday.
The risk of blood clots is higher following COVID-19 infection than after vaccination, researchers based at Oxford University reported today in BMJ.
Two US outbreaks of Salmonella, one S Typhimurium and the other S Infantis, have been linked to Italian-style meats, although none are connected to a specific product or brand yet, according to a Centers for Disease Control and Prevention (CDC) investigation notice today.
The Ivory Coast yesterday launched an Ebola vaccination campaign aimed at frontline health workers and other high-risk groups, part of the response into an imported Ebola case involving a woman who had just arrived from Guinea.
Inhaled budesonide, a corticosteroid often used for Crohn's disease, was tied to a shorter recovery time in COVID-19 patients who were at a higher risk of severe infection, according to a study published in The Lancet yesterday.
Vaccine effectiveness (VE) for the Pfizer/BioNTech COVID-19 vaccine against COVID-19 was 91% up to 6 months after the second dose, according to a non–peer-reviewed study published yesterday on the preprint server medRxiv.
Half of patients hospitalized with severe COVID-19 across 302 UK hospitals developed one or more health complications within 28 days or discharge, according to a study yesterday in The Lancet.
A urine culture stewardship initiative at a teaching hospital in Michigan reduced overuse of urine cultures and was associated with a significant decline in catheter-associated urinary tract infections (CAUTIs), researchers reported today in Infection Control & Hospital Epidemiology.
The prevalence of the colistin-resistance gene MCR-1 in healthy residents of a Chinese city declined following China's ban on colistin as a growth promoter in livestock in 2017, researchers reported today in Clinical Microbiology and Infection. But seafood may be an emerging risk factor for MCR-1 colonization.
A modeling study yesterday suggests that the first human case of COVID-19 likely occurred in or around November 2019 in China, with the most likely date of origin being Nov 17. The study was published in PLOS Pathogens.
